Mia's Feed
Medical News & Research

Long-Term Cardiac Microvascular Changes in Severe COVID-19 Survivors

Long-Term Cardiac Microvascular Changes in Severe COVID-19 Survivors

Share this article

Severe COVID-19 survivors may experience prolonged cardiac microvascular dysfunction, impacting blood flow and heart function. New research underscores the importance of understanding these lasting effects for better treatment options.

1 min read

Recent research from Karolinska Institutet highlights persistent cardiac complications in patients who endured severe COVID-19. The study examined approximately 40 individuals from a post-COVID outpatient clinic using advanced cardiac imaging techniques. Findings revealed reduced blood flow through the heart muscle and impaired pumping function compared to matched controls, suggesting the presence of small vessel disease long after initial infection.

Particularly, patients exhibited signs of microvascular dysfunction, which may contribute to ongoing symptoms like fatigue and exercise intolerance. Midventricular perfusion maps demonstrated globally diminished perfusion under stress conditions, indicating widespread microvascular impairment.

The research emphasizes the importance of understanding the underlying mechanisms of enduring COVID-19 symptoms. As Associate Professor Jannike Nickander explains, small vessel disease could be a key factor and a potential target for therapeutic intervention. Her team is now investigating the molecular pathways involved and exploring the interactions between cardiac and pulmonary pressures in these patients.

This study highlights the need for ongoing monitoring and research into cardiovascular health in COVID-19 survivors, aiming to improve treatment strategies and patient outcomes.

Source: https://medicalxpress.com/news/2025-06-small-vessel-disease-term-severe.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Promising Early Findings of Niraparib in Treating Advanced Melanoma

Early clinical trial results indicate that niraparib, a PARP inhibitor, shows promise in treating advanced melanoma with specific genetic mutations, potentially expanding targeted therapy options for patients.

How Excess Body Fat Impairs the Brain's Immune Defense in Alzheimer's Disease

Emerging research reveals that excess fat within brain immune cells impairs their function, contributing to Alzheimer's progression. New insights point to lipid metabolism as a promising target for therapy.

The Vital Impact of Community and Family Support on Health Behavior Change and Outcomes

Research highlights the critical role of community and family support in changing health behaviors and reducing cardiovascular disease risk among Latino populations through culturally tailored interventions and systemic improvements.